From October 1, 2022 to December 16, 2022, the company has repurchased 107,590 shares, representing 0.53% for CAD 0.07 million. With this, the company has completed the repurchase of 663,600 shares, representing 3.19% for CAD 1.06 million under the buyback announced on December 15, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 CAD | -2.33% | -2.33% | -14.29% |
May. 08 | Crescita Therapeutics Q1 Loss Widens, Revenue Rises | MT |
May. 08 | Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million | MT |
1st Jan change | Capi. | |
---|---|---|
-14.29% | 5.98M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- CTX Stock
- News Crescita Therapeutics Inc.
- Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on December 15, 2021.